Fig. 2

Pooled prevalence of abnormal CMR findings in patients who recovered from COVID-19. a Pooled prevalence of total abnormal CMR findings. b Pooled prevalence of the diagnosis of myocarditis on CMR. c Pooled prevalence of pericardial late gadolinium enhancement (LGE). d Pooled prevalence of myocardial LGE. e Pooled prevalence of LGE (pericardial or myocardial). f Pooled prevalence of native T1 abnormality on the T1 map. g Pooled prevalence of T2 abnormality. h Pooled prevalence of LGE without T2 abnormality. i Pooled prevalence of T2 abnormality without LGE. j Pooled prevalence of pericardial effusion. k Pooled prevalence of ventricular systolic dysfunction. CMR, cardiovascular magnetic resonance; COVID-19, coronavirus disease 2019; LGE, late gadolinium enhancement